These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29664030)

  • 1. Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?
    Pereira P; Kapoor A; Sinha A; Agarwal SK; Pande S; Khanna R; Srivastava N; Kumar S; Garg N; Tewari S; Goel P
    Indian J Med Res; 2017 Dec; 146(6):722-729. PubMed ID: 29664030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.
    Hlatky MA; Solomon MD; Shilane D; Leong TK; Brindis R; Go AS
    J Am Coll Cardiol; 2013 Jan; 61(3):295-301. PubMed ID: 23246391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
    Kawashima H; Serruys PW; Ono M; Hara H; O'Leary N; Mack MJ; Holmes DR; Morice MC; Head SJ; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Sharif F; McEvoy JW; Onuma Y;
    J Am Coll Cardiol; 2021 Jul; 78(1):27-38. PubMed ID: 34210411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
    Fox DJ; Kibiro M; Eichhöfer J; Curzen NP
    Postgrad Med J; 2005 Jun; 81(956):401-3. PubMed ID: 15937208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Trends in Adherence to Secondary Prevention Guidelines for Patients Undergoing Coronary Revascularization in Washington State: An Analysis of the Clinical Outcomes Assessment Program (COAP) Registry.
    Riley RF; Don CW; Aldea GS; Mokadam NA; Probstfield J; Maynard C; Goss JR
    J Am Heart Assoc; 2012 Aug; 1(5):e002733. PubMed ID: 26600570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease.
    Jia S; Zhang C; Jiang L; Xu L; Tian J; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Gao Z; Yuan J; Song L
    Circ J; 2020 Sep; 84(10):1718-1727. PubMed ID: 32848116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry.
    Okrainec K; Pilote L; Platt R; Eisenberg MJ
    Can J Cardiol; 2006 Aug; 22(10):841-7. PubMed ID: 16957801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery.
    Filion KB; Pilote L; Rahme E; Eisenberg MJ
    J Card Surg; 2008; 23(3):209-15. PubMed ID: 18435634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention.
    Ardati AK; Pitt B; Smith DE; Aronow HD; Share D; Moscucci M; Chetcuti S; Grossman PM; Gurm HS
    Am Heart J; 2013 May; 165(5):778-84. PubMed ID: 23622915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes N; Gersh BJ; Soares PR; Ribeiro EE; Pereira AC; Favarato D; Rocha AS; Hueb AC; Ramires JA
    Circulation; 2010 Sep; 122(10):949-57. PubMed ID: 20733102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study.
    Wijeysundera HC; Bennell MC; Qiu F; Ko DT; Tu JV; Wijeysundera DN; Austin PC
    J Gen Intern Med; 2014 Jul; 29(7):1031-9. PubMed ID: 24610309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical therapy in revascularized coronary artery disease patients].
    Liu XH; DU X; Kang JP; Lü Q; Zhang Q; Lü SZ; Chen F; Ma CS
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):236-9. PubMed ID: 18361833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery.
    Varghese I; Samuel J; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2009; 10(2):103-9. PubMed ID: 19327672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of multiple chronic total occlusions in coronary arteries according to three therapeutic strategies: Bypass surgery, percutaneous intervention and medication.
    Kim BS; Yang JH; Jang WJ; Song YB; Hahn JY; Choi JH; Kim WS; Lee YT; Gwon HC; Lee SH; Choi SH
    Int J Cardiol; 2015 Oct; 197():2-7. PubMed ID: 26113468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.